Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Johnson and Johnson
Colorcon
Dow
AstraZeneca

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018689

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 018689 describes RIDAURA, which is a drug marketed by Sebela Ireland Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the RIDAURA profile page.

The generic ingredient in RIDAURA is auranofin. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the auranofin profile page.
Summary for 018689
Tradename:RIDAURA
Applicant:Sebela Ireland Ltd
Ingredient:auranofin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018689
Suppliers and Packaging for NDA: 018689
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIDAURA auranofin CAPSULE;ORAL 018689 NDA Sebela Pharmaceuticals Inc. 54766-093 54766-093-06 60 CAPSULE in 1 BOTTLE (54766-093-06)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength3MG
Approval Date:May 24, 1985TE:RLD:Yes

Expired US Patents for NDA 018689

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
Dow
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.